LPL Financial’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-11,664
| Closed | -$128K | – | 4745 |
|
|
2023
Q3 | $128K | Sell |
11,664
-4,000
| -26% | -$43.8K | ﹤0.01% | 4313 |
|
|
2023
Q2 | $202K | Sell |
15,664
-1,615
| -9% | -$20.9K | ﹤0.01% | 4096 |
|
|
2023
Q1 | $207K | Sell |
17,279
-591
| -3% | -$7.09K | ﹤0.01% | 3991 |
|
|
2022
Q4 | $245K | Sell |
17,870
-1,243
| -7% | -$17.1K | ﹤0.01% | 3795 |
|
|
2022
Q3 | $280K | Hold |
19,113
| – | – | ﹤0.01% | 3624 |
|
|
2022
Q2 | $290K | Sell |
19,113
-190
| -1% | -$2.88K | ﹤0.01% | 3628 |
|
|
2022
Q1 | $347K | Buy |
19,303
+10,865
| +129% | +$195K | ﹤0.01% | 3456 |
|
|
2021
Q4 | $201K | Sell |
8,438
-1,633
| -16% | -$38.9K | ﹤0.01% | 3968 |
|
|
2021
Q3 | $306K | Sell |
10,071
-2,321
| -19% | -$70.5K | ﹤0.01% | 3607 |
|
|
2021
Q2 | $395K | Hold |
12,392
| – | – | ﹤0.01% | 3352 |
|
|
2021
Q1 | $371K | Sell |
12,392
-784
| -6% | -$23.5K | ﹤0.01% | 3286 |
|
|
2020
Q4 | $418K | Sell |
13,176
-3,810
| -22% | -$121K | ﹤0.01% | 2903 |
|
|
2020
Q3 | $466K | Sell |
16,986
-318
| -2% | -$8.72K | ﹤0.01% | 2518 |
|
|
2020
Q2 | $469K | Sell |
17,304
-1,043
| -6% | -$28.3K | ﹤0.01% | 2433 |
|
|
2020
Q1 | $358K | Buy |
18,347
+688
| +4% | +$13.4K | ﹤0.01% | 2342 |
|
|
2019
Q4 | $414K | Sell |
17,659
-3,487
| -16% | -$81.8K | ﹤0.01% | 2520 |
|
|
2019
Q3 | $397K | Sell |
21,146
-479
| -2% | -$8.99K | ﹤0.01% | 2447 |
|
|
2019
Q2 | $457K | Sell |
21,625
-9,406
| -30% | -$199K | ﹤0.01% | 2334 |
|
|
2019
Q1 | $652K | Sell |
31,031
-35,796
| -54% | -$752K | ﹤0.01% | 1978 |
|
|
2018
Q4 | $1.26M | Buy |
66,827
+19,031
| +40% | +$359K | ﹤0.01% | 1354 |
|
|
2018
Q3 | $1.19M | Buy |
47,796
+2,310
| +5% | +$57.4K | ﹤0.01% | 1538 |
|
|
2018
Q2 | $1.1M | Sell |
45,486
-74,706
| -62% | -$1.8M | ﹤0.01% | 1551 |
|
|
2018
Q1 | $3.49M | Buy |
120,192
+77,718
| +183% | +$2.26M | 0.01% | 849 |
|
|
2017
Q4 | $1.01M | Buy |
42,474
+11,131
| +36% | +$265K | ﹤0.01% | 1517 |
|
|
2017
Q3 | $848K | Buy |
31,343
+10,619
| +51% | +$287K | ﹤0.01% | 1543 |
|
|
2017
Q2 | $477K | Sell |
20,724
-2,292
| -10% | -$52.8K | ﹤0.01% | 1913 |
|
|
2017
Q1 | $553K | Sell |
23,016
-2,461
| -10% | -$59.1K | ﹤0.01% | 1716 |
|
|
2016
Q4 | $551K | Sell |
25,477
-10,879
| -30% | -$235K | ﹤0.01% | 1672 |
|
|
2016
Q3 | $934K | Sell |
36,356
-361
| -1% | -$9.27K | 0.01% | 1249 |
|
|
2016
Q2 | $864K | Sell |
36,717
-47,047
| -56% | -$1.11M | 0.01% | 1276 |
|
|
2016
Q1 | $1.9M | Buy |
83,764
+34,226
| +69% | +$775K | 0.01% | 1233 |
|
|
2015
Q4 | $1.36M | Buy |
+49,538
| New | +$1.36M | ﹤0.01% | 1441 |
|